Atlas Trials

Aspirin for Prevention of Venous Thromboembolism Among Ovarian Cancer Patients Receiving Neoadjuvant Chemotherapy

Clinical trial NCT04352439 · COMPLETED

Trial details

NCT number
NCT04352439
Sponsor
Duke University
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Venous ThromboembolismOvarian Cancer
Start date
2020-08-08
Primary completion
2022-03-02
Enrollment
19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.